Just Other Articles

Many people have the idea that bridging loans are expensive. They have hea

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

rd that getting this kind of finance costs too much and are therefore put

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

off getting quotes or applying further. The truth is a bridging loan is th

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

e only kind of secured financial product that can raise any amount from ?2

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

5,500 to several million pounds. A typical example of costs would be a ?10

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

0,000 loan that is charged at 0.76% per month. The interest charged for ea

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ch month the bridging loan is needed for would be ?760.00.

The repayment

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

period can be paid between 1 and 36 months so the monthly amount payable c

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

an be made to suit your budget. Bridging finance is therefore more expensi

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ve than a mortgage but a cheap way out to solve many problems. A few examp

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

es of ways a bridging loan can be profitable will now be looked at.

Examp

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

le 1 A person sees a house or piece of land for sale at auction. In order

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

to prevent losing the property and deposit a bridging loan is arranged unt

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

il a more permanent mortgage is finalized.

Example 2 A business has run o

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ut of funds and needs to take advantage of a venture like buying some stoc

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

k at a cheap price. A bridging loan is arranged, the the stock is bought t

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

en sold at a profit. The bridging loan is then repayed and the company ma

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

kes a healthy profit.

Example 3 A person is just about to complete on the

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

purchase of a house and then just at the last minute their buyer pulls ou

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

t. A bridging loan is used to bridge the gap until thier old house is sold

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/89530/justotherarticles-Are-Bridging-Loans-Expensive.html">Are Bridging Loans Expensive?</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/89530/justotherarticles-Are-Bridging-Loans-Expensive.html]Are Bridging Loans Expensive?[/url]

You find them in all spheres of society – in cubicles, on the shop floor, on the sports field, in the marching crowd of protesters, as huge as in the CEO-chair, yet as small as on the nursery school playground. They are the minority group of people impacting on the majority of society – whether positive or negative – but they are of one breed: the leaders. However, the real leaders – those who make it to be examples in the business bestsellers – have one particular commonality that is easy to spot: MATURITY.

A couple months back I had a little plumbing problem that required turning off the water to the house. Our do-it-yourself job was great until we needed to turn the water back on and nothing happened.

You sell more than one service or product, but you cannot assume that anyone knows about everything you have to offer - even your past clients! Here are some things you can do to assure that your prospects don't go elsewhere to purchase what you provide, simply because they don't know that you provide it.

Tags

Links

Just Other Articles - Are Bridging Loans Expensive?

Related Articles: